EU-PEARL

EU-PEARL

EU Patient-Centric Clinical Trial Platforms EU-PEARL is a strategic partnership between the public and private sectors to shape the future of clinical trials. This innovative and challenging enterprise aims to create a tested and trusted framework for patient-centric...
PARADIGM

PARADIGM

Patients Active in Research and Dialogues for an Improved Generation of Medicines The overall goal is to provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development...
RESCEU

RESCEU

RESCEU aims to investigate serious lung infections caused by respiratory syncytial virus (RSV) that particularly affect babies and older people, and those with weakened immune systems, including cancer patients and people with chronic lung diseases such as emphysema....
ARITMO

ARITMO

ARITMO – Arrhythmogenic potential of drugs The ARITMO project aimed to analyse the arrhythmic potential of drugs in the following classes of study drugs (> 250 compounds): antipsychotics, anti-infectives (antibacterials, antimycotics and antivirals ) and...
ETOX

ETOX

Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities (eTOX) With a budget of over 18.5 million €, the project is undertaken by a consortium of 30 organisations led by Novartis,...